Introduction
Symbos is a medication that contains the active ingredient Voglibose. It is used to manage blood sugar levels in patients with type 2 diabetes mellitus.
Uses
Symbos is prescribed to help control high blood sugar levels in individuals with type 2 diabetes mellitus. It is often used in combination with other medications, diet, and exercise to achieve optimal blood sugar control.
Dosage and Administration
The typical dosage of Symbos is determined by the healthcare provider based on the patient’s individual needs and response to treatment. It is usually taken orally, with or immediately before meals. Patients should follow their healthcare provider’s instructions regarding the timing and frequency of administration.
Mechanism of Action
Voglibose, the active ingredient in Symbos, works by inhibiting certain enzymes in the intestine. This inhibition slows down the breakdown of complex carbohydrates into glucose, thereby reducing the postprandial rise in blood sugar levels.
Side Effects
Common side effects of Symbos may include abdominal discomfort, flatulence, and diarrhea. Serious side effects are rare but may include severe allergic reactions. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, or severe skin rashes.
Drug Interactions
Symbos may interact with other medications, including certain antidiabetic agents, leading to an increased risk of hypoglycemia. It is important for patients to inform their healthcare provider about all the medications, supplements, and herbal products they are currently using to avoid potential interactions.
Precautions
Patients with a known hypersensitivity to Voglibose or any components of Symbos should avoid its use. Additionally, individuals with certain digestive disorders or intestinal blockage should not take this medication. Discuss any existing medical conditions and ongoing treatments with the healthcare provider before starting Symbos.
Storage
Symbos should be stored at room temperature, away from excessive heat and moisture. Keep the medication out of the reach of children and pets.
Patient Tips
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Voglibose (International database) (Drugs.com) [Accessed 12 Jun. 2024] (online) Available at:
- Hara T, Hotta N. [Voglibose]. Nihon Rinsho. 1997 Nov;55 Suppl:114-9. [Accessed 18 Jun. 2024] Available at:
- Ciprofloxacin (Intratympanic) Advanced Patient Information Consumer Information (Micromedex) (Drugs.com) [Accessed 0 Jun. 2024] (online) Available at:
- Chavda V, Patel S. Voglibose and saxagliptin ameliorate the post-surgical stress and cognitive dysfunction in chronic anaesthesia exposed diabetic MCAo induced ischemic rats. IBRO Neurosci Rep. 2022 Nov 1;13:426-435. doi: 10.1016/j.ibneur.2022.10.009. eCollection 2022 Dec. [Accessed 5 Jun. 2024] Available at:
Reviews
There are no reviews yet.